• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的风险因素。

Risk factors for Alzheimer's disease.

机构信息

Vision Sciences, Aston University, Birmingham, United Kingdom.

出版信息

Folia Neuropathol. 2019;57(2):87-105. doi: 10.5114/fn.2019.85929.

DOI:10.5114/fn.2019.85929
PMID:31556570
Abstract

Early reviews identified over 20 risk factors associated with Alzheimer's disease (AD) including age, familial inheritance, exposure to aluminium, traumatic brain injury (TBI), and associated co-morbidities such as vascular disease and infection. In the light of recent evidence, this review reconsiders these risk factors, identifies those currently regarded as important, and discusses various hypotheses to explain how they may cause AD. Rare forms of early-onset familial AD (EO-FAD) are strongly linked to causal gene mutations, viz. mutations in amyloid precursor protein (APP) and presenilin (PSEN1/2) genes. By contrast, late-onset sporadic AD (LO-SAD) is a multifactorial disorder in which age-related changes, genetic risk factors, such as allelic variation in apolipoprotein E (Apo E) and many other genes, vascular disease, TBI and risk factors associated with diet, the immune system, mitochondrial function, metal exposure, and infection are all implicated. These risk factors may act collectively to cause AD pathology: 1) by promoting the liberation of oxygen free radicals with age, 2) via environmental stress acting on regulatory genes early and later in life ('dual hit' hypothesis), or 3) by increasing the cumulative 'allostatic load' on the body over a lifetime. As a consequence, life-style changes which reduce the impact of these factors may be necessary to lower the risk of AD.

摘要

早期的研究报告确定了 20 多种与阿尔茨海默病(AD)相关的风险因素,包括年龄、家族遗传、接触铝、创伤性脑损伤(TBI)以及血管疾病和感染等相关的合并症。鉴于最近的证据,本次综述重新考虑了这些风险因素,确定了目前被认为重要的因素,并讨论了各种假设,以解释它们如何导致 AD。早发性家族性 AD(EO-FAD)的罕见形式与致病基因突变密切相关,即淀粉样前体蛋白(APP)和早老素(PSEN1/2)基因的突变。相比之下,迟发性散发性 AD(LO-SAD)是一种多因素疾病,其中年龄相关的变化、遗传风险因素,如载脂蛋白 E(Apo E)等位基因变异和许多其他基因、血管疾病、TBI 以及与饮食、免疫系统、线粒体功能、金属暴露和感染相关的风险因素都与之相关。这些风险因素可能共同作用导致 AD 病理:1)随着年龄的增长促进氧自由基的释放,2)通过环境应激作用于调节基因,早期和晚期(“双重打击”假说),或 3)通过一生中对身体的累积“适应负荷”增加。因此,改变生活方式以减轻这些因素的影响可能是降低 AD 风险的必要条件。

相似文献

1
Risk factors for Alzheimer's disease.阿尔茨海默病的风险因素。
Folia Neuropathol. 2019;57(2):87-105. doi: 10.5114/fn.2019.85929.
2
What causes alzheimer's disease?阿尔茨海默病的病因是什么?
Folia Neuropathol. 2013;51(3):169-88. doi: 10.5114/fn.2013.37702.
3
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
4
[Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].[晚发型阿尔茨海默病的遗传学:血管风险与β-淀粉样蛋白代谢]
Recenti Prog Med. 2002 Sep;93(9):489-97.
5
Laminar distribution of β-amyloid (Aβ) peptide deposits in the frontal lobe in familial and sporadic Alzheimer's disease.家族性和散发性阿尔茨海默病中β-淀粉样蛋白(Aβ)肽沉积物在额叶的层状分布。
Folia Neuropathol. 2015;53(1):15-23. doi: 10.5114/fn.2015.49970.
6
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.组织蛋白酶D外显子2 C→T多态性与阿尔茨海默病之间的遗传关联以及与基因型的病理相关性。
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7. doi: 10.1136/jnnp.2005.063917.
7
Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.阿尔茨海默病β-淀粉样前体蛋白的运输与代谢调控
Biochim Biophys Acta. 2000 Jul 26;1502(1):44-52. doi: 10.1016/s0925-4439(00)00031-4.
8
New frontiers in Alzheimer's disease genetics.阿尔茨海默病遗传学的新前沿
Neuron. 2001 Oct 25;32(2):181-4. doi: 10.1016/s0896-6273(01)00476-7.
9
Molecular genetics of Alzheimer's disease.阿尔茨海默病的分子遗传学
Geriatrics. 1997 Sep;52 Suppl 2:S9-12.
10
[Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].阿尔茨海默病淀粉样前体蛋白的分子生物学进展与临床研究
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Apr;26(2):201-9.

引用本文的文献

1
Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease.对胰高血糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂作为阿尔茨海默病潜在治疗方法的真实世界观察。
Alzheimers Dement. 2025 Sep;21(9):e70639. doi: 10.1002/alz.70639.
2
Ocular changes as potential biomarkers for early diagnosis of Alzheimer's disease.眼部变化作为阿尔茨海默病早期诊断的潜在生物标志物。
Alzheimers Dement. 2025 Aug;21(8):e70476. doi: 10.1002/alz.70476.
3
Epidemiology and risk factors of Alzheimer's disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis protocol.
南亚和东南亚地区阿尔茨海默病及相关痴呆症的流行病学与风险因素:一项系统综述和荟萃分析方案
BMJ Open. 2025 Aug 21;15(8):e105955. doi: 10.1136/bmjopen-2025-105955.
4
Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential.解析自分泌运动因子和溶血磷脂酸在阿尔茨海默病中的作用:从分子机制到治疗潜力
Int J Mol Sci. 2025 Jul 23;26(15):7068. doi: 10.3390/ijms26157068.
5
Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer's Disease Are Associated with the Peripheral Suppression of Inflammation.中枢胰岛素样生长因子-1在散发性阿尔茨海默病大鼠模型中诱导的抗焦虑和抗抑郁作用与外周炎症抑制有关。
Cells. 2025 Aug 1;14(15):1189. doi: 10.3390/cells14151189.
6
Association between weight-adjusted waist circumference index and risk of cognitive decline in Chinese hypertensive patients: a case-control study.体重校正腰围指数与中国高血压患者认知功能减退风险的关联:一项病例对照研究。
Front Public Health. 2025 Jul 16;13:1632358. doi: 10.3389/fpubh.2025.1632358. eCollection 2025.
7
Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.AL101(GSK4527226),一种能提高原纤维蛋白水平的单克隆抗体,作为阿尔茨海默病潜在治疗方法的研发。
Alzheimers Res Ther. 2025 Jul 25;17(1):174. doi: 10.1186/s13195-025-01817-4.
8
Advances in Genetic Risk Scores for Alzheimer's Disease and Dementia: A Systematic Review.阿尔茨海默病和痴呆症遗传风险评分的进展:一项系统综述
Neurol Int. 2025 Jun 26;17(7):99. doi: 10.3390/neurolint17070099.
9
Critical Review of Neurobiological Evidence for Relationships Between Social Isolation, Loneliness and the Risk of Developing of Alzheimer's Disease: A New Model.社会隔离、孤独与患阿尔茨海默病风险之间关系的神经生物学证据批判性综述:一种新模型
J Aging Res. 2025 Jul 2;2025:9924448. doi: 10.1155/jare/9924448. eCollection 2025.
10
Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease.线粒体DNA影响衰老和阿尔茨海默病中的tau蛋白磷酸化。
Alzheimers Dement. 2025 Jul;21(7):e70390. doi: 10.1002/alz.70390.